Both hematopoietic-derived and non-hematopoietic-derived β-arrestin-2 regulates murine allergic airway disease

American Journal of Respiratory Cell and Molecular Biology

Volumn 43, Issue 3, 2010, Pages 269-275

  Hollingsworth, John W ^a   Theriot, Barbara S ^a   Li, Zhouwei ^a   Lawson, Barbara L ^a   Sunday, Mary ^a   Schwartz, David A ^b   Walker, Julia K L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

arrestin 2; Airway hyperresponsiveness; Asthma; Bone marrow transplant

Indexed keywords

BETA ARRESTIN 2; CHEMOKINE; OVALBUMIN; BETA ARRESTIN; INTERLEUKIN 13; RETINA S ANTIGEN;

ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CELL STRUCTURE; CELL TYPE; CHEMOTAXIS; CHIMERA; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; FEMALE; HEMATOPOIETIC CELL; HOSPITALIZATION; MACROPHAGE MIGRATION; MORBIDITY; MOUSE; NONHUMAN; PATHOGENESIS; REGULATORY MECHANISM; T LYMPHOCYTE; ADOPTIVE TRANSFER; ANIMAL; BONE MARROW; BONE MARROW TRANSPLANTATION; C57BL MOUSE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; LUNG; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; RESPIRATORY SYSTEM;

MURINAE; MUS;

ADOPTIVE TRANSFER; ANIMALS; ARRESTINS; ASTHMA; BONE MARROW; BONE MARROW TRANSPLANTATION; EOSINOPHILS; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; INTERLEUKIN-13; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OVALBUMIN; RESPIRATORY SYSTEM; T-LYMPHOCYTES;

EID: 77956627575     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2009-0198OC     Document Type: Article

References (34)

1. Centers for Disease Control. Asthma prevalence and control characteristics by race/ethnicity - United States. MMWR 2004;53:145-148.
2. National Heart, Lung, and Blood Institute. Morbidity and mortality: 2002 chartbook on cardiovascular, lung and blood disease. Bethesda, MD: US Department of Health and Human Services; 2002.
3. Deshpande DA, Penn RB. Targeting G protein-coupled receptor signaling in asthma. Cell Signal 2006;18:2105-2120. (Pubitemid 44636173)
4. Probst WC, Snyder LA, Schuster DI, Brosius J, Sealfon SC. Sequence alignment of the G-protein coupled receptor superfamily. DNA Cell Biol 1992;11:1-20.
5. Ahamed J., Haribabu B., Ali H. Cutting edge: differential regulation of chemoattractant receptor-induced degranulation and chemokine production by receptor phosphorylation. J Immunol 2001;167:3559-3563. (Pubitemid 32910796)
6. Barlic J, Andrews J, Kelvin A, Bosinger S, DeVries M, Xu L, Dobransky T, Feldman R, Ferguson S, Kelvin D. Regulation of tyrosine kinase activation and granule release through beta-arrestin by CXCR1. Nat Immunol 2000;13:227-233.
7. DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK. Beta-arrestins and cell signaling. Annu Rev Physiol 2007;69:483-510.
8. Attramadal H, Arriza JL, Aoki C, Dawson TM, Codina J, Kwatra MM, Snyder SH, Caron MG, Lefkowitz RJ. Beta-arrestin2, a novel member of the arrestin/beta-arrestin gene family. J Biol Chem 1992;267:17882-17890.
9. Miller WE, Lefkowitz RJ. Expanding roles for beta-arrestins as scaffolds and adapters in GPCR signaling and trafficking. Curr Opin Cell Biol 2001;13:139-145.
10. Pierce KL, Lefkowitz RJ. Classical and new roles of beta-arrestins in the regulation of G-protein-coupled receptors. Nat Rev Neurosci 2001;2:727-733.
11. Benovic JL, Kuhn H, Weyand I, Codina J, Caron MG, Lefkowitz RJ. Functional desensitization of the isolated beta-adrenergic receptor by the beta-adrenergic receptor kinase: potential role of an analog of the retinal protein arrestin (48-kDa protein). Proc Natl Acad Sci USA 1987;84:8879-8882.
12. Lefkowitz RJ, Whalen EJ. [Beta]-arrestins: traffic cops of cell signaling. Curr Opin Cell Biol 2004;16:162-168.
13. Lloyd C. Chemokines in allergic lung inflammation. Immunology 2002; 105:144-154.
14. Walker JKL, Fong AM, Lawson BL, Savov JD, Patel DD, Schwartz DA, Lefkowitz RJ. Beta-arrestin22 regulates the development of allergic asthma. J Clin Invest 2003;112:566-574. (Pubitemid 38056341)
15. Grunig G, Warnock M, Wakil AE, Venkayya R, Brombacher F, Rennick DM, Sheppard D, Mohrs M, Donaldson DD, Locksley RM, et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998;282:2261-2263. (Pubitemid 29004075)
16. Hollingsworth JW, Chen BJ, Brass DM, Berman K, Gunn MD, Cook DN, Schwartz DA. The critical role of hematopoietic cells in lipopolysaccharide-induced airway inflammation. Am J Respir Crit Care Med 2005;171:806-813. (Pubitemid 40562710)
17. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, Donaldson DD. Interleukin-13: central mediator of allergic asthma. Science 1998;282:2258-2261. (Pubitemid 29004074)
18. Gavett SH, Wills-Karp M. Elevated lung G protein levels and muscarinic receptor affinity in a mouse model of airway hyperreactivity. Am J Physiol Lung Cell Mol Physiol 1993;265:L493-L500. (Pubitemid 2015836)
19. Levitt RC, Mitzner W. Expression of airway hyperreactivity to acetylcholine as a simple autosomal recessive trait in mice. FASEB J 1988;2:2605-2608.
20. Motusky H. Intuitive biostatistics. New York: Oxford University Press, Inc.; 1995.
21. Deshpande DA, Theriot BS, Penn RB, Walker JKL. {Beta}-arrestins specifically constrain {beta}2-adrenergic receptor signaling and function in airway smooth muscle. FASEB J 2008;22:2134-2141.
22. Fong AM, Premont RT, Richardson RM, Yu YA, Lefkowitz RJ, Patel DD. A positive regulatory role for the β-arrestin-GRK system in lymphocyte chemotaxis. Proc Natl Acad Sci USA 2002;99:7478-7483.
23. Lampinen M, Carlson M, Ha° kansson L, Venge P. Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy 2004;59:793-805.
24. Lefkowitz RJ, Rajagopal K, Whalen EJ. New roles for [beta]-arrestins in cell signaling: not just for seven-transmembrane receptors. Mol Cell 2006;24:643-652.
25. Ge L, Ly Y, Hollenberg M, DeFea KA. {Beta}-arrestin-dependent scaffold is associated with prolonged MAPK activation in pseudopodia during protease-activated receptor-2-induced chemotaxis. J Biol Chem 2003;278:34418-34426. (Pubitemid 37553288)
26. Hunton D, Barnes W, Kim J, Ren X, Violin J, Reiter E, Milligan G, Patel D, Lefkowitz R. Beta-arrestin 2-dependent angiotensin II type 1A receptor-mediated pathway of chemotaxis. Mol Pharmacol 2005;67:1229-1236.
27. Sun Y, Cheng Z, Ma L, Pei G. Beta-arrestin2 is critically involved in CXCR4-mediated chemotaxis and this is mediated by its enhancement of p38 MAPK activation. J Biol Chem 2002;277:49212-49219.
28. Sabroe I, Jorritsma A, Stubbs V, Xanthou G, Jopling L, Ponath P, Williams T, Murphy P, Pease J. The carboxyl terminus of the chemokine receptor CCR3 contains distinct domains which regulate chemotactic signaling and receptor down-regulation in a ligand-dependent manner. Eur J Immunol 2005;35:1301-1310.
29. Currie G, Lee D, Lipworth B. Long-acting beta2-agonists in asthma: not so SMART? Drug Saf 2006;29:647-656.
30. Krupnick JG, Goodman OB Jr, Keen JH, Benovic JL. Arrestin/clathrin interaction. Localization of the clathrin binding domain of nonvisual arrestins to the carboxyl terminus. J Biol Chem 1997;272:15011-15016.
31. Laporte SA, Miller WE, Kim K-M, Caron MG. Beta -arrestin/AP-2 interaction in G protein-coupled receptor internalization. J Biol Chem 2002;277:9247-9254.
32. Lohse MJ, Benovic JL, Codina J, Caron MG, Lefkowitz RJ. Beta-arrestin: a protein that regulates beta-adrenergic receptor function. Science 1990;248:1547-1550.
33. Hirst SJ. Regulation of airway smooth muscle cell immunomodulatory function: role in asthma. Respir Physiol Neurobiol 2003;137:309-326. (Pubitemid 37153290)
34. Wang Y, Bai C, Li K, Adler KB, Wang X. Role of airway epithelial cells in development of asthma and allergic rhinitis. Respir Med 2008;102:949-955.